<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">31198220</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0042-4668</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>84</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Vestnik otorinolaringologii</Title>
          <ISOAbbreviation>Vestn Otorinolaringol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Vascular mechanisms in Meniere's disease].</ArticleTitle>
        <Pagination>
          <StartPage>70</StartPage>
          <EndPage>77</EndPage>
          <MedlinePgn>70-77</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.17116/otorino20198402170</ELocationID>
        <Abstract>
          <AbstractText>Meniere's disease (MD) is chronic multifactorial medical condition caused by endolymphatic hydrops, which etiology is unclear. This review highlights possible vascular mechanisms of MD. Impairment of vascular regulation, further ischemic damage of labyrinth and venous drainage pathology could lead to endolymphatic hydrops. Epidemiologic studies reveal high comorbidity of MD and migraine. Both diseases could be the result of trigeminovascular dysfunction. Betahistine, the medication with vascular effect, is widely used in treatment of MD, the effectiveness of calcium channel blockers is evaluated. Keywords: vertigo, Meniere's disease, endolymphatichydrops, migraine, vascular mechanisms, betahistine.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kutlubaev</LastName>
            <ForeName>M A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Kuvatov Republican Clinical Hospital, Ufa, Russia, 450005</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Bashkir State Medical University of the Ministry of Health of Russia, Ufa, Russia, 450000</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pal'chun</LastName>
            <ForeName>V T</ForeName>
            <Initials>VT</Initials>
            <AffiliationInfo>
              <Affiliation>N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Moscow, Russia, 117997</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sverzhevsky Research Institute of Clinical Otorhinolaryngology, Moscow, Russia, 117152</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Savel'eva</LastName>
            <ForeName>E E</ForeName>
            <Initials>EE</Initials>
            <AffiliationInfo>
              <Affiliation>Bashkir State Medical University of the Ministry of Health of Russia, Ufa, Russia, 450000</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guseva</LastName>
            <ForeName>A L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Moscow, Russia, 117997</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>rus</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Sosudistye mekhanizmy v razvitii bolezni Men'era.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Russia (Federation)</Country>
        <MedlineTA>Vestn Otorinolaringol</MedlineTA>
        <NlmUniqueID>0416577</NlmUniqueID>
        <ISSNLinking>0042-4668</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D007758" MajorTopicYN="N">Ear, Inner</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018159" MajorTopicYN="Y">Endolymphatic Hydrops</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008575" MajorTopicYN="Y">Meniere Disease</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008881" MajorTopicYN="Y">Migraine Disorders</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014717" MajorTopicYN="N">Vertigo</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>Болезнь Меньера (БМ) - хроническое полиэтиологичное заболевание, связанное с развитием эндолимфатического гидропса (ЭГ). Этиология БМ неясна. В статье приводится обзор сосудистых механизмов, которые могут лежать в основе развития данного заболевания. По экспериментальным данным, нарушение регуляции кровоснабжения и последующие ишемические повреждения лабиринта, а также нарушение венозного оттока от внутреннего уха могут стать причинами ЭГ. Эпидемиологические исследования указывают на высокую частоту коморбидности БМ и мигрени. Оба заболевания могут быть связаны с дисфункцией тригеминоваскулярной системы. В лечении БМ часто используется бетагистин, который обладает вазотропными свойствами, исследуется эффективность блокаторов кальциевых каналов.</AbstractText>
      </OtherAbstract>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31198220</ArticleId>
        <ArticleId IdType="doi">10.17116/otorino20198402170</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
